Whole Proteome-Based Therapeutic Targets Annotation and Designing of Multi-Epitope-Based Vaccines against the

Metab Alharbi1, Abdulrahman Alshammari1, Abdullah F Alasmari1

  • 1Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia.

Vaccines
|March 26, 2022
PubMed

Insights

This study identifies new vaccine targets against drug-resistant Alcaligenes faecalis infections. Computational methods were used to design and validate potential vaccines, offering hope for novel antimicrobial therapies.

Area of Science:

  • Microbiology
  • Vaccinology
  • Computational Biology

Background:

  • Alcaligenes faecalis is a multidrug-resistant bacterium causing human infections.
  • Existing antibiotics are increasingly ineffective against this pathogen.
  • Novel therapeutic strategies, including vaccines, are urgently needed.

Purpose of the Study:

  • To identify potential therapeutic targets in Alcaligenes faecalis.
  • To design and validate in silico putative vaccines against this bacterium.
  • To assess the feasibility of these vaccine candidates for further development.

Main Methods:

  • Subtractive proteomics for whole proteome annotation.
  • Immune epitope prediction and prioritization.
  • In silico vaccine design, structural validation, and molecular docking with human TLR-2.
  • In silico cloning and immune simulation.

Main Results:

  • Identification and prioritization of specific target proteins within Alcaligenes faecalis.
  • Successful in silico design and validation of putative vaccine constructs.
  • Demonstrated potential interaction with human TLR-2, suggesting immunogenicity.
  • Feasibility assessment for vaccine construct development confirmed through simulation.

Conclusions:

  • This study presents a computational pipeline for developing novel vaccines against Alcaligenes faecalis.
  • The identified vaccine candidates show promise for combating drug-resistant bacterial infections.
  • In silico validation provides a strong foundation for experimental vaccine development.